| Restoration of liver sinusoidal cell phenotypes by statins improves portal hypertension and histology in rats with NASH M Bravo, I Raurell, D Hide, A Fernández-Iglesias, M Gil, A Barberá, ... Scientific reports 9 (1), 20183, 2019 | 50 | 2019 |
| Synergic effect of atorvastatin and ambrisentan on sinusoidal and hemodynamic alterations in a rat model of NASH M Bravo, I Raurell, A Barberá, D Hide, M Gil, F Estrella, MT Salcedo, ... Disease Models & Mechanisms 14 (5), dmm048884, 2021 | 14 | 2021 |
| Simvastatin-loaded polymeric micelles are more effective and less toxic than conventional statins in a pre-clinical model of advanced chronic liver disease D Hide, M Gil, F Andrade, D Rafael, I Raurell, M Bravo, A Barbera, ... Nanomedicine: Nanotechnology, Biology and Medicine 29, 102267, 2020 | 13 | 2020 |
| Steatosis as main determinant of portal hypertension through a restriction of hepatic sinusoidal area in a dietary rat nash model A Barberá, I Raurell, T García‐Lezana, M Torres‐Arauz, M Bravo, D Hide, ... Liver International 40 (11), 2732-2743, 2020 | 5 | 2020 |
| A nine-strain bacterial consortium improves portal hypertension and insulin signaling and delays NAFLD progression in vivo I Pinheiro, A Barberá, I Raurell, F Estrella, M de Leeuw, S Bolca, ... Biomedicines 10 (5), 1191, 2022 | 3 | 2022 |
| Proteomic Analysis of Dysfunctional Liver Sinusoidal Endothelial Cells Reveals Substantial Differences in Most Common Experimental Models of Chronic Liver Diseases M Gil, M Azkargorta, C Fuster, M Martínez-Gómez, I Raurell, A Barberá, ... International Journal of Molecular Sciences 24 (15), 11904, 2023 | 1 | 2023 |
| A translational rat model to study metabolic associated fatty liver disease with fibrosis and portal hypertension A Barberá, I Raurell, M Martínez-Gómez, M Gil, JM Pericàs, J Genesca, ... Journal of Hepatology 78, S780, 2023 | | 2023 |
| Liver steatosis induces portal hypertension regardless of fibrosis in patients with NAFLD: A proof of concept case report J Rivera-Esteban, A Barberá, MT Salcedo, M Martell, J Genescà, ... JHEP Reports 5 (1), 2023 | | 2023 |
| A nine-strain bacterial consortium improves portal hypertension and insulin signaling and delays non-alcoholic fatty liver disease progression in vivo I Pinheiro, A Barbera, I Raurell, F Estrella, M de Leeuw, S Bolca, ... Journal of Hepatology 77, S180, 2022 | | 2022 |
| STEATOSIS AS MAIN DETERMINANT OF PORTAL HYPERTENSION THROUGH A CRITICAL RESTRICTION OF HEPATIC SINUSOIDAL AREA IN A DIET-INDUCED RAT MODEL OF NON-ALCOHOLIC STEATOHEPATITIS A Barbera, I Raurell, T Garcia-Lezana, M Bravo, J Genesca, M Martell, ... HEPATOLOGY 70, 1097A-1098A, 2019 | | 2019 |
| Proteomic analysis of dysfunctional liver sinusoidal endothelial cells reveals substantial differences in most common experimental models of chronic liver diseases M Gil, C Fuster, M Azkargorta, I Raurell, A Barbera, F Elortza, J Genesca, ... Hepatology 61 (5), 1740-6, 2015 | | 2015 |
